MedPath

Isosorbide

Generic Name
Isosorbide
Drug Type
Small Molecule
Chemical Formula
C6H10O4
CAS Number
652-67-5
Unique Ingredient Identifier
WXR179L51S
Background

Isosorbide was previously available in an oral formulation for the reduction of intraocular pressure. It was approved by the FDA in 1980, but has since been discontinued. Currently, isosorbide is an organic nitrate currently available in the isosorbide mononitrate and isosorbide dinitrate forms, and is used for the prevention of angina. Refer to these drug entries for more information.

Indication

Isosorbide was previously indicated for temporary reduction of intraocular pressure and used to interrupt an acute glaucoma attack, however, this is not a currently approved indication. Refer to isosorbide mononitrate and isosorbide dinitrate drug entries for more isosorbide indications.

Associated Conditions
Angina Pectoris

Isosorbide Mononitrate in Induction of Labour

First Posted Date
2020-07-23
Last Posted Date
2020-07-23
Lead Sponsor
Aljazeera Hospital
Target Recruit Count
130
Registration Number
NCT04482881
Locations
🇪🇬

Algazeerah, Giza, Egypt

Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention

Not Applicable
Conditions
Post-ERCP Acute Pancreatitis
Interventions
Drug: Rectal placebo
Drug: Sublingual Placebo
First Posted Date
2020-06-11
Last Posted Date
2020-10-22
Lead Sponsor
Air Force Military Medical University, China
Target Recruit Count
2700
Registration Number
NCT04425993
Locations
🇨🇳

Xijing Hoapital, Xi'an, Shaanxi, China

🇨🇳

Lanzhou University Second Hospital, Lanzhou, Gansu, China

🇨🇳

Xi'an Central Hospital, Xi'an, Shaanxi, China

and more 1 locations

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

Phase 3
Conditions
Contraception
Interventions
First Posted Date
2020-03-17
Last Posted Date
2020-03-17
Lead Sponsor
Cairo University
Target Recruit Count
88
Registration Number
NCT04311658

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

Phase 4
Completed
Conditions
Antispastic Therapy
Coronary Artery Bypass Graft
Radial Artery Grafts
Pilot Study
Interventions
First Posted Date
2020-03-17
Last Posted Date
2024-12-12
Lead Sponsor
Ruijin Hospital
Target Recruit Count
150
Registration Number
NCT04310995
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

Multiomics After Headache Provocation of People Who Are Unable to Have Headache

Not Applicable
Completed
Conditions
Headache
Healthy
Interventions
First Posted Date
2020-01-06
Last Posted Date
2021-03-25
Lead Sponsor
Danish Headache Center
Target Recruit Count
58
Registration Number
NCT04218760
Locations
🇩🇰

Danish Headache Center, Glostrup, Region H, Denmark

Headache Provocation of People Who Are Unable to Have Headache

Not Applicable
Completed
Conditions
Headache
Healthy
Interventions
First Posted Date
2020-01-03
Last Posted Date
2021-03-25
Lead Sponsor
Danish Headache Center
Target Recruit Count
58
Registration Number
NCT04217668
Locations
🇩🇰

Danish Headache Center, Glostrup, Region H, Denmark

Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor

Phase 1
Conditions
Induction of Labor
Interventions
First Posted Date
2018-05-14
Last Posted Date
2018-08-07
Lead Sponsor
Dina Yahia Mansour
Target Recruit Count
50
Registration Number
NCT03523754
Locations
🇪🇬

Department of Obs & Gyn,Faculty of Medicine, Ain shams University., Cairo, Egypt

LACunar Intervention (LACI-2) Trial-2

Phase 2
Completed
Conditions
Cerebral Small Vessel Diseases
Stroke, Lacunar
Interventions
First Posted Date
2018-03-02
Last Posted Date
2024-11-11
Lead Sponsor
University of Edinburgh
Target Recruit Count
363
Registration Number
NCT03451591
Locations
🇬🇧

Royal Infirmary, Edinburgh, Lothian, United Kingdom

Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients

Phase 1
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2017-08-21
Last Posted Date
2021-12-29
Lead Sponsor
Bayer
Target Recruit Count
41
Registration Number
NCT03255512
Locations
🇩🇪

Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany

🇩🇪

Medizinische Einrichtungen der Universität Bonn, Bonn, Nordrhein-Westfalen, Germany

🇩🇪

SocraTec R&D GmbH, Erfurt, Thüringen, Germany

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath